EDIT: Editas well Positioned in CRSPR

The Harvard/MIT Broad Institute won a court case validating their CRSPR patents, and EDIT (Editas) is one way to be exposed to that. Its hard to develop a good comparison, but the competition licensed technology from the loser and look at the valuation grid:

CRSPR is increasingly looking like a viable medical technology that can be instrumental in curing…